EUVIMEDEUVIMED entdecken
Crossref

IDH1 and IDH2 Gene Role in Glioma

Abrar Hussain

Journal of Molecular and Cellular Life Sciences · 2026

DOI: 10.67238/jmbc.2026.v2.01 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular and Cellular Life Sciences, 2026. Verfasst von Abrar Hussain.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioma is a type of tumor originating from glial cells in the brain and spinal cord. It primarily affects astrocytes, oligodendrocytes, and ependymal cells. Mutations in the Isocitrate Dehydrogenase 1 (IDH1) and Isocitrate Dehydrogenase 2 (IDH2) genes are pivotal in gliomagenesis, particularly in diffuse lower-grade gliomas and secondary glioblastomas. These mutations, especially at R132 in IDH1 and R172 in IDH2, confer a neomorphic activity converting α-ketoglutarate (α-KG) to D-2-hydroxyglutarate (2-HG). Elevated 2-HG disrupts α-KG–dependent dioxygenases, resulting in genome-wide epigenetic modifications, collectively termed the glioma CpG island methylator phenotype (G-CIMP). Clinically, these mutations correlate with younger age at diagnosis, favorable prognosis, and improved survival. IDH mutations are now essential in the 2021 WHO classification of CNS tumors. Targeted therapies such as ivosidenib, enasidenib, and vorasidenib aim to reverse 2-HG accumulation. This commentary outlines the molecular basis, clinical impact, and therapeutic opportunities related to IDH1/2 mutations in glioma.

Zitieren

APA

Hussain, A. (2026). IDH1 and IDH2 Gene Role in Glioma. Journal of Molecular and Cellular Life Sciences. https://doi.org/10.67238/jmbc.2026.v2.01

Vancouver

Hussain A. IDH1 and IDH2 Gene Role in Glioma. Journal of Molecular and Cellular Life Sciences. 2026. doi:10.67238/jmbc.2026.v2.01

BibTeX
@article{Hussain2026,
  author = {Hussain, Abrar},
  title = {IDH1 and IDH2 Gene Role in Glioma},
  journal = {Journal of Molecular and Cellular Life Sciences},
  year = {2026},
  doi = {10.67238/jmbc.2026.v2.01}
}
Kostenlos starten →